Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Prophylactic efficacy of enteral miconazole administration for neonatal intestinal perforation and its potential mechanism.

Torikai M, Ibara S, Ieiri S, Hamada T, Noguchi H, Sueyoshi K, Fukuda T, Abeyama K.

Pediatr Surg Int. 2016 Oct;32(10):953-7. doi: 10.1007/s00383-016-3946-6. Epub 2016 Jul 29.

PMID:
27473010
2.

Muscle wasting associated with pathologic change is a risk factor for the exacerbation of joint swelling in collagen-induced arthritis in cynomolgus monkeys.

Horai N, Nagaoka T, Higuchi I, Kasai H, Yoshioka T, Umekita Y, Fukuzaki K, Nagata R, Miyata A, Abeyama K.

BMC Musculoskelet Disord. 2013 Jul 9;14:205. doi: 10.1186/1471-2474-14-205.

3.

1,5-anhydro-D-fructose and its derivatives: biosynthesis, preparation and potential medical applications.

Fiskesund R, Abeyama K, Yoshinaga K, Abe J, Yuan Y, Yu S.

Planta Med. 2010 Oct;76(15):1635-41. doi: 10.1055/s-0030-1250120. Epub 2010 Jul 19. Review.

PMID:
20645241
4.

Gene expression profiling during rat mammary carcinogenesis induced by 7,12-dimethylbenz[a]anthracene.

Souda M, Umekita Y, Abeyama K, Yoshida H.

Int J Cancer. 2009 Sep 15;125(6):1285-97. doi: 10.1002/ijc.24396.

5.

Relevance of apoptosis and tolerance to hypoxic stress in cells transfected with receptor for advanced glycation end products (RAGE).

Hiwatashi K, Ueno S, Kubo F, Sakoda M, Tateno T, Hayashi T, Abeyama K, Natsugoe S.

Anticancer Res. 2009 Apr;29(4):1287-94.

6.

Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis.

Hamada T, Torikai M, Kuwazuru A, Tanaka M, Horai N, Fukuda T, Yamada S, Nagayama S, Hashiguchi K, Sunahara N, Fukuzaki K, Nagata R, Komiya S, Maruyama I, Fukuda T, Abeyama K.

Arthritis Rheum. 2008 Sep;58(9):2675-85. doi: 10.1002/art.23729.

7.

The role of water channel aquaporin 3 in the mechanism of TNF-alpha-mediated proinflammatory events: Implication in periodontal inflammation.

Tancharoen S, Matsuyama T, Abeyama K, Matsushita K, Kawahara K, Sangalungkarn V, Tokuda M, Hashiguchi T, Maruyama I, Izumi Y.

J Cell Physiol. 2008 Nov;217(2):338-49. doi: 10.1002/jcp.21506.

PMID:
18543247
8.

A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC.

Hiwatashi K, Ueno S, Abeyama K, Kubo F, Sakoda M, Maruyama I, Hamanoue M, Natsugoe S, Aikou T.

Ann Surg Oncol. 2008 Mar;15(3):923-33. Epub 2007 Dec 15.

9.

Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification.

Taniguchi N, Yoshida K, Ito T, Tsuda M, Mishima Y, Furumatsu T, Ronfani L, Abeyama K, Kawahara K, Komiya S, Maruyama I, Lotz M, Bianchi ME, Asahara H.

Mol Cell Biol. 2007 Aug;27(16):5650-63. Epub 2007 Jun 4.

10.

High-mobility group box 1 protein promotes development of microvascular thrombosis in rats.

Ito T, Kawahara K, Nakamura T, Yamada S, Nakamura T, Abeyama K, Hashiguchi T, Maruyama I.

J Thromb Haemost. 2007 Jan;5(1):109-16.

11.

Hydroxyapatite formed on/in agarose gel induces activation of blood coagulation and platelets aggregation.

Arimura S, Kawahara K, Biswas KK, Abeyama K, Tabata M, Shimoda T, Ogomi D, Matsusaki M, Kato S, Ito T, Sugihara K, Akashi M, Hashiguchi T, Maruyama I.

J Biomed Mater Res B Appl Biomater. 2007 May;81(2):456-61.

PMID:
17022065
12.

The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.

Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M, Uchimura T, Ida N, Yamazaki Y, Yamada S, Yamamoto Y, Yamamoto H, Iino S, Taniguchi N, Maruyama I.

J Clin Invest. 2005 May;115(5):1267-74. Epub 2005 Apr 14.

13.

Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation.

Yamaji K, Wang Y, Liu Y, Abeyama K, Hashiguchi T, Uchimura T, Krishna Biswas K, Iwamoto H, Maruyama I.

Thromb Res. 2005;115(4):319-25.

PMID:
15668192
14.

[Inflammation and its regulatory system].

Abeyama K, Maruyama I.

Nihon Rinsho. 2004 Dec;62(12):2229-35. Review. Japanese.

PMID:
15597789
15.

The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value.

Iino S, Abeyama K, Kawahara K, Yamakuchi M, Hashiguchi T, Matsukita S, Yonezawa S, Taniguchi S, Nakata M, Takao S, Aikou T, Maruyama I.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6179-88.

16.

Decreased total nitric oxide production in patients with duchenne muscular dystrophy.

Kasai T, Abeyama K, Hashiguchi T, Fukunaga H, Osame M, Maruyama I.

J Biomed Sci. 2004 Jul-Aug;11(4):534-7.

PMID:
15153790
17.
18.

Anti-atherogenic effects of an egg yolk-enriched garlic supplement.

Yamaji K, Sarker KP, Abeyama K, Maruyama I.

Int J Food Sci Nutr. 2004 Feb;55(1):61-6.

PMID:
14630593
19.

Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis.

Biswas KK, Sarker KP, Abeyama K, Kawahara K, Iino S, Otsubo Y, Saigo K, Izumi H, Hashiguchi T, Yamakuchi M, Yamaji K, Endo R, Suzuki K, Imaizumi H, Maruyama I.

Hepatology. 2003 Nov;38(5):1167-77.

PMID:
14578855
20.

Antibiotic cyclic AMP signaling by "primed" leukocytes confers anti-inflammatory cytoprotection.

Abeyama K, Kawahara K, Iino S, Hamada T, Arimura S, Matsushita K, Nakajima T, Maruyama I.

J Leukoc Biol. 2003 Nov;74(5):908-15. Epub 2003 Aug 1.

PMID:
12960287
21.

Anandamide induces apoptosis in human endothelial cells: its regulation system and clinical implications.

Yamaji K, Sarker KP, Kawahara K, Iino S, Yamakuchi M, Abeyama K, Hashiguchi T, Maruyama I.

Thromb Haemost. 2003 May;89(5):875-84.

PMID:
12719786
22.

Temporomandibular disorders: relationship between joint pain and effusion and nitric oxide concentration in the joint fluid.

Suenaga S, Abeyama K, Hamasaki A, Mimura T, Noikura T.

Dentomaxillofac Radiol. 2001 Jul;30(4):214-8.

PMID:
11681483
23.

Temporomandibular disorders: MR assessment of inflammatory changes in the posterior disk attachment during the menstrual cycle.

Suenaga S, Abeyama K, Indo H, Shigeta K, Noikura T.

J Comput Assist Tomogr. 2001 May-Jun;25(3):476-81.

PMID:
11351201
24.

Enhanced production of vascular endothelial growth factor by human monocytic cells stimulated with endotoxin through transcription factor SP-1.

Sakuta T, Matsushita K, Yamaguchi N, Oyama T, Motani R, Koga T, Nagaoka S, Abeyama K, Maruyama I, Takada H, Torii M.

J Med Microbiol. 2001 Mar;50(3):233-7.

PMID:
11232768
25.

The role of vascular endothelial growth factor in human dental pulp cells: induction of chemotaxis, proliferation, and differentiation and activation of the AP-1-dependent signaling pathway.

Matsushita K, Motani R, Sakuta T, Yamaguchi N, Koga T, Matsuo K, Nagaoka S, Abeyama K, Maruyama I, Torii M.

J Dent Res. 2000 Aug;79(8):1596-603.

PMID:
11023281
26.

A role for NF-kappaB-dependent gene transactivation in sunburn.

Abeyama K, Eng W, Jester JV, Vink AA, Edelbaum D, Cockerell CJ, Bergstresser PR, Takashima A.

J Clin Invest. 2000 Jun;105(12):1751-9.

27.

Inhibition of thrombin-induced neuronal cell death by recombinant thrombomodulin and E5510, a synthetic thrombin receptor signaling inhibitor.

Sarker KP, Abeyama K, Nishi J, Nakata M, Tokioka T, Nakajima T, Kitajima I, Maruyama I.

Thromb Haemost. 1999 Sep;82(3):1071-7.

PMID:
10494766
28.

Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture.

Matsushita K, Motani R, Sakuta T, Nagaoka S, Matsuyama T, Abeyama K, Maruyama I, Takada H, Torii M.

Infect Immun. 1999 Apr;67(4):1633-9.

29.

Inflammatory cytokine production and specific antibody responses against possible causative bacteria in patients with multilesional periapical periodontitis.

Matsushita K, Tajima T, Tomita K, Abeyama K, Maruyama I, Takada H, Nagaoka S.

J Endod. 1998 Dec;24(12):817-21.

PMID:
10023261
30.

Angiosarcoma of the tongue: report of a case with immunohistochemical findings.

Tabata M, Sugihara K, Matsui R, Yonezawa S, Abeyama K, Maruyama I.

J Oral Pathol Med. 1999 Feb;28(2):92-5. Review.

PMID:
9950257
32.

MRI of the temporomandibular joint disk and posterior disk attachment before and after nonsurgical treatment.

Suenaga S, Sonoda S, Oku T, Abeyama K, Noikura T.

J Comput Assist Tomogr. 1997 Nov-Dec;21(6):892-6.

PMID:
9386278
33.

Nitric oxide production in the lesions of temporomandibular disorders and gender differences in nitric oxide production.

Abeyama K, Maruyama I, Suenaga S, Noikura T.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Oct;84(4):330-1. No abstract available.

PMID:
9347490
34.

Induction of apoptosis in murine clonal osteoblasts expressed by human T-cell leukemia virus type I tax by NF-kappa B and TNF-alpha.

Kitajima I, Nakajima T, Imamura T, Takasaki I, Kawahara K, Okano T, Tokioka T, Soejima Y, Abeyama K, Maruyama I.

J Bone Miner Res. 1996 Feb;11(2):200-10.

PMID:
8822344
35.

Thrombin receptor-mediated synovial proliferation in patients with rheumatoid arthritis.

Shin H, Nakajima T, Kitajima I, Shigeta K, Abeyama K, Imamura T, Okano T, Kawahara K, Nakamura T, Maruyama I.

Clin Immunol Immunopathol. 1995 Sep;76(3 Pt 1):225-33.

PMID:
7554443
36.

Nonionic contrast agents produce thrombotic effect by inducing adhesion of leukocytes on human endothelium.

Abeyama K, Oh S, Kawano K, Nakajima T, Soejima Y, Nakano K, Maruyama I.

Biochem Biophys Res Commun. 1995 Jul 26;212(3):776-83.

PMID:
7542889
37.

Interleukin 6 mediated differentiation and rescue of cell redox in PC12 cells exposed to ionizing radiation.

Abeyama K, Kawano K, Nakajima T, Takasaki I, Kitajima I, Maruyama I.

FEBS Lett. 1995 May 15;364(3):298-300.

38.

Involvement of NF-kappa B activation in thrombin-induced human vascular smooth muscle cell proliferation.

Nakajima T, Kitajima I, Shin H, Takasaki I, Shigeta K, Abeyama K, Yamashita Y, Tokioka T, Soejima Y, Maruyama I.

Biochem Biophys Res Commun. 1994 Oct 28;204(2):950-8.

PMID:
7980566
39.

[Treatment results of small cell lung cancer: referring to the clinical value of BAI combined with radiotherapy].

Miyaji N, Oyama T, Uchiyama N, Abeyama K, Onohara S, Ogita M, Ito Y, Nakajo M, Okubo K, Tanohata S.

Nihon Igaku Hoshasen Gakkai Zasshi. 1993 Dec 25;53(12):1436-44. Japanese.

PMID:
8108248
40.

[Percutaneous injection of cisplatin lipiodol suspension (CLS) in rabbit lung, aiming at intratumoral injection therapy for lung cancer].

Onohara S, Nakajo M, Abeyama K, Shinmaki H, Sagara K, Mukai H, Uchiyama N, Miyaji N, Harada O, Hiraki Y, et al.

Nihon Igaku Hoshasen Gakkai Zasshi. 1992 Oct 25;52(10):1433-42. Japanese.

PMID:
1333070
41.

[Transarterial "pile-up" infusion therapy of cisplatin and lipiodol emulsion in hepatic malignancies without TAE (transcatheter arterial embolization)].

Onohara S, Ogita M, Shimada J, Hiraki Y, Abeyama K, Nakajo M.

Gan To Kagaku Ryoho. 1992 Mar;19(3):315-21. Japanese.

PMID:
1311912
42.

[Magnetic resonance imaging of the adrenal gland].

Ogita M, Oyama T, Onohara S, Nakabeppu Y, Mukai H, Abeyama K, Shinohara S.

Nihon Igaku Hoshasen Gakkai Zasshi. 1991 Dec 25;51(12):1431-41. Japanese.

PMID:
1792151

Supplemental Content

Loading ...
Support Center